Received: 16 January 2018
Accepted: 25 November 2018
First Online: 22 January 2019
Ethics approval and consent to participate
: Compassionate use of ceftazidime/avibactam combination for our patient was approved by the local Ethics Committee “Regione Abruzzo, Comitato Etico per la ricerca biomedica delle provicie di Chieti e Pescara.”
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.